Connecticut officials announced the settlement with Mylan on Thursday. It resolves allegations that the pharmaceutical ...
Check your medicine cabinet ASAP.
By Mrinalika Roy Oct 28 (Reuters) - Women in the US struggling to find hormone replacement treatments to manage menopause ...
Viatris is a company that requires different preparation than other foreign pharmaceutical firms. It was formed on November ...
Dr. Kiran Kota joins Intas Pharmaceuticals as VP – API Quality, bringing 25+ years of experience in pharmaceutical quality ...
The Attorney General's Office says Mylan violated state antitrust and consumer protection laws and will provide Connecticut ...
Dry eye is common, hormonally mediated, and underrecognized in menopause, and a study argues clinicians should screen for it.
HARTFORD, Conn. (WTNH) — The State of Connecticut has settled an $8 million lawsuit with pharmaceutical company Mylan over allegations the company illegally inflated EpiPen prices, Attorney General ...
Vitaris is recalling tablets of its generic telmisartan and amlodipine, in 40-milligram and 5-milligram doses.
Viatris has rebounded 50% YTD, driven by a return to growth and operating leverage after years of stagnation and execution issues. I rate the VTRS stock a hold.